Trial Profile
The Diurnal and Nocturnal Effect of Tafluprost on Intraocular Pressure and Ocular Perfusion Pressure
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2017
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 06 Nov 2017 New trial record